Drugs News and Research

RSS

'As-needed' treatment OK for children with mild asthma

Children with mild asthma may use two inhalers – one steroid and the other a bronchodilator, when symptoms occur, a new study shows.

19 Aug 2019

Protein governing platinum-resistant ovarian cancer identified

The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center.

18 Aug 2019

FDA approves first spinal tether device to treat children with idiopathic scoliosis

The U.S. Food and Drug Administration today approved the first spinal tether device intended to be used in children and adolescents to correct the most common form of scoliosis, called idiopathic scoliosis, that has not responded to conservative treatment options, such as external bracing.

18 Aug 2019

Research finds lack of racial diversity in clinical trials for cancer drugs

New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs.

18 Aug 2019

Hospital pharmacist-led approach can reduce antibiotic use

In small, community hospitals that don't have resources for a dedicated staff to oversee the proper use of antibiotics, turning to staff pharmacists showed promise in a model study conducted by Duke Health.

18 Aug 2019

FDA approves new drug to treat patients with myelofibrosis

Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients with certain types of myelofibrosis.

18 Aug 2019

FDA approves novel device to treat symptoms associated with advanced heart failure

The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.

18 Aug 2019

Fruit fly model for studying diseases like gout, kidney stones reveals new drug targets

A new fruit fly model that mimics diseases associated with high uric acid levels, such as gout and kidney stones, has revealed new targets for developing treatments for these diseases.

From PLOS ONE 16 Aug 2019

Among hurdles for those with opioid addictions: Getting the drug to treat it

Louis Morano knew what he needed, and he knew where to get it. He made his way to a mobile medical clinic parked on a corner of Philadelphia's Kensington neighborhood, in the geographical heart of the city's overdose crisis. People call it "the bupe bus."

16 Aug 2019

Rapid European adoption of Carterra’s LSA platform fuels expansion

Carterra Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a Customer Experience Center and office in Munich, Germany. Rapid European adoption of Carterra’s platform has fueled the need for the new office.

From Carterra Inc. 16 Aug 2019

Study finds no harm to newborns from opioid maintenance treatment during pregnancy

A new Pharmacology Research & Perspectives study found no harm to newborns from opioid maintenance treatment (OMT) during pregnancy compared with no treatment.

16 Aug 2019

Scientists find a potent weapon against antibiotic resistance

Antibiotic resistance is a big threat to global health, and a growing number of infections are now becoming harder to treat. The usual treatments, like antibiotics used to treat them, becomes less effective. Now, a team of researchers may have found a potent weapon against antibiotic-resistant bacteria, which can help treat persistent infections.

15 Aug 2019

Herpes treatment greatly improved by adding charcoal

A novel charcoal-based drug-delivery system to treat herpes infections topically shows greatly improved efficacy over conventional treatment. Here, the medication called acyclovir, commonly used for herpes infection, was combined with activated carbon particles.

15 Aug 2019

FDA approves effective new treatment for extremely drug-resistant tuberculosis

Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).

15 Aug 2019

Removal of a critical enzyme may help cases of sepsis finds research

Scientists at the University of California San Diego School of Medicine have shown that removal of an enzyme called the PH domain Leucine-rich repeat Protein Phosphatase 1 (PHLPP1) could help laboratory mice with sepsis in a model they had created for their experiment. The study titled, “PHLPP1 counter-regulates STAT1-mediated inflammatory signalling,” was published this week in the journal eLife.

15 Aug 2019